Synaptogenix, Inc.
SNPX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2 | $2 | $6 | $4 |
| G&A Expenses | $5,212,010 | $6 | $10 | $8 |
| SG&A Expenses | $5 | $6 | $10 | $8 |
| Sales & Mktg Exp. | -$5,212,005 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $7 | $8 | $16 | $13 |
| Operating Income | -$7 | -$8 | -$26 | -$13 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$6 | $2 | $11 | $0 |
| Pre-Tax Income | -$13 | -$6 | -$6 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13 | -$6 | -$5 | -$13 |
| % Margin | – | – | – | – |
| EPS | -10.99 | -29.56 | -20.35 | -62.87 |
| % Growth | 62.8% | -45.3% | 67.6% | – |
| EPS Diluted | -10.99 | -29.56 | -20.35 | -62.87 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$13 | -$8 | -$16 | -$13 |
| % Margin | – | – | – | – |